Further implications on the global real-world vaccine effectiveness against SARS-CoV-2

Rontgene Solante; Carlos Alvarez-Moreno; Erlina Burhan; Suwat Chariyalertsak; Nan Chang Chiu; Sunate Chuenkitmongkol; Dung Do-Van; Kao Pin Hwang; Sasisopin Kiertiburanakul; Ping Ing Lee; Rommel Crisenio Lobo; Alejandro Macias; Cao Huu Nghia; Anna Ong-Lim; Javier Ortiz Ibarra; Rosana Richtmann; Alfonso J. Rodriguez-Morales; Marco Aurélio P. Safadi; Hindra Irawan Satari

doi:10.1080/14760584.2022.2110073

Further implications on the global real-world vaccine effectiveness against SARS-CoV-2

Rontgene Solante, Carlos Alvarez-Moreno, Erlina Burhan, Suwat Chariyalertsak, Nan Chang Chiu, Sunate Chuenkitmongkol, Dung Do-Van, Kao Pin Hwang, Sasisopin Kiertiburanakul, Ping Ing Lee, Rommel Crisenio Lobo, Alejandro Macias, Cao Huu Nghia, Anna Ong-Lim, Javier Ortiz Ibarra, Rosana Richtmann, Alfonso J. Rodriguez-Morales, Marco Aurélio P. Safadi, Hindra Irawan Satari

Research output: Contribution to journal › Letter › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	1355-1357
Number of pages	3
Journal	Expert Review of Vaccines
Volume	21
Issue number	9
DOIs	https://doi.org/10.1080/14760584.2022.2110073
Publication status	Published - 2022

Keywords

4th dose
AZD1222
BNT162b2
booster
COVID-19
Southeast Asia
Thailand
vaccine effectiveness

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/14760584.2022.2110073

Cite this

Solante, R., Alvarez-Moreno, C., Burhan, E., Chariyalertsak, S., Chiu, N. C., Chuenkitmongkol, S., Do-Van, D., Hwang, K. P., Kiertiburanakul, S., Lee, P. I., Lobo, R. C., Macias, A., Nghia, C. H., Ong-Lim, A., Ortiz Ibarra, J., Richtmann, R., Rodriguez-Morales, A. J., Safadi, M. A. P., & Satari, H. I. (2022). Further implications on the global real-world vaccine effectiveness against SARS-CoV-2. Expert Review of Vaccines, 21(9), 1355-1357. https://doi.org/10.1080/14760584.2022.2110073

@article{c2cbe4a821e44ccdaec1feda136cdf7b,

title = "Further implications on the global real-world vaccine effectiveness against SARS-CoV-2",

keywords = "4th dose, AZD1222, BNT162b2, booster, COVID-19, Southeast Asia, Thailand, vaccine effectiveness",

author = "Rontgene Solante and Carlos Alvarez-Moreno and Erlina Burhan and Suwat Chariyalertsak and Chiu, {Nan Chang} and Sunate Chuenkitmongkol and Dung Do-Van and Hwang, {Kao Pin} and Sasisopin Kiertiburanakul and Lee, {Ping Ing} and Lobo, {Rommel Crisenio} and Alejandro Macias and Nghia, {Cao Huu} and Anna Ong-Lim and {Ortiz Ibarra}, Javier and Rosana Richtmann and Rodriguez-Morales, {Alfonso J.} and Safadi, {Marco Aur{\'e}lio P.} and Satari, {Hindra Irawan}",

note = "Funding Information: R Solante discloses consulting fees from AstraZeneca. C Alvarez-Moreno discloses grants from WHO solidarity COVID-19 vaccine studies, and speaker from GSK, Pfizer, Astra Zeneca. E Burhan, KP Hwang, A Macia, CH Nghia, JO Ibarra, HI Satari, A Rodriguez-Morales and S Chariyalertsak disclose consulting fees from AstraZeneca. NC Chiu discloses consulting fees from AstraZeneca and honoraria for scientific meeting travel and lecture from multiple companies. He is also a member of the Taiwan Vaccine Injury Compensation Program and Pediatric Infectious Disease Society of Taiwan. DV Dung discloses consulting fees and honoraria for advisory board attendance by AstraZeneca. S Kiertiburanakul discloses consulting fees from AstraZeneca and honoraria for lectures from AstraZeneca, Pfizer and Zuellig Pharma. PI Lee discloses grants from the Taiwan Center for Disease Control for COVID-19 vaccine immunogenicity studies, consulting fees from AstraZeneca, Merck Sharp & Dohme (MSD), and GlaxoSmithKline and payment for lectures from MSD. He also serves as the Chair, Advisory Committee on Immunization Practice in Taiwan. RC Lobo discloses consulting fees from AstraZeneca and honoraria for lectures from Menarini Philippines, Nestle, Mead Johnson and Novartis. He is also the vice-chair of the National Adverse Events Following Immunization committee in the Philippines. A Ong-Lim discloses honoraria for lectures from Moderna and is a member of the Technical Advisory Group, Department of Health in the Philippines. R Richtmann discloses consulting fees from AstraZeneca and honoraria for lectures from Pfizer and J&J. MAP Safadi discloses research grants and consultancy fees from Pfizer, GlaxoSmithKline, MSD, AstraZeneca, Janssen, and Sanofi-Pasteur.",

year = "2022",

doi = "10.1080/14760584.2022.2110073",

language = "English",

volume = "21",

pages = "1355--1357",

journal = "Expert Review of Vaccines",

issn = "1476-0584",

publisher = "Taylor and Francis Ltd.",

number = "9",

}

Solante, R, Alvarez-Moreno, C, Burhan, E, Chariyalertsak, S, Chiu, NC, Chuenkitmongkol, S, Do-Van, D, Hwang, KP, Kiertiburanakul, S, Lee, PI, Lobo, RC, Macias, A, Nghia, CH, Ong-Lim, A, Ortiz Ibarra, J, Richtmann, R, Rodriguez-Morales, AJ, Safadi, MAP & Satari, HI 2022, 'Further implications on the global real-world vaccine effectiveness against SARS-CoV-2', Expert Review of Vaccines, vol. 21, no. 9, pp. 1355-1357. https://doi.org/10.1080/14760584.2022.2110073

TY - JOUR

T1 - Further implications on the global real-world vaccine effectiveness against SARS-CoV-2

AU - Solante, Rontgene

AU - Alvarez-Moreno, Carlos

AU - Burhan, Erlina

AU - Chariyalertsak, Suwat

AU - Chiu, Nan Chang

AU - Chuenkitmongkol, Sunate

AU - Do-Van, Dung

AU - Hwang, Kao Pin

AU - Kiertiburanakul, Sasisopin

AU - Lee, Ping Ing

AU - Lobo, Rommel Crisenio

AU - Macias, Alejandro

AU - Nghia, Cao Huu

AU - Ong-Lim, Anna

AU - Ortiz Ibarra, Javier

AU - Richtmann, Rosana

AU - Rodriguez-Morales, Alfonso J.

AU - Safadi, Marco Aurélio P.

AU - Satari, Hindra Irawan

N1 - Funding Information: R Solante discloses consulting fees from AstraZeneca. C Alvarez-Moreno discloses grants from WHO solidarity COVID-19 vaccine studies, and speaker from GSK, Pfizer, Astra Zeneca. E Burhan, KP Hwang, A Macia, CH Nghia, JO Ibarra, HI Satari, A Rodriguez-Morales and S Chariyalertsak disclose consulting fees from AstraZeneca. NC Chiu discloses consulting fees from AstraZeneca and honoraria for scientific meeting travel and lecture from multiple companies. He is also a member of the Taiwan Vaccine Injury Compensation Program and Pediatric Infectious Disease Society of Taiwan. DV Dung discloses consulting fees and honoraria for advisory board attendance by AstraZeneca. S Kiertiburanakul discloses consulting fees from AstraZeneca and honoraria for lectures from AstraZeneca, Pfizer and Zuellig Pharma. PI Lee discloses grants from the Taiwan Center for Disease Control for COVID-19 vaccine immunogenicity studies, consulting fees from AstraZeneca, Merck Sharp & Dohme (MSD), and GlaxoSmithKline and payment for lectures from MSD. He also serves as the Chair, Advisory Committee on Immunization Practice in Taiwan. RC Lobo discloses consulting fees from AstraZeneca and honoraria for lectures from Menarini Philippines, Nestle, Mead Johnson and Novartis. He is also the vice-chair of the National Adverse Events Following Immunization committee in the Philippines. A Ong-Lim discloses honoraria for lectures from Moderna and is a member of the Technical Advisory Group, Department of Health in the Philippines. R Richtmann discloses consulting fees from AstraZeneca and honoraria for lectures from Pfizer and J&J. MAP Safadi discloses research grants and consultancy fees from Pfizer, GlaxoSmithKline, MSD, AstraZeneca, Janssen, and Sanofi-Pasteur.

PY - 2022

Y1 - 2022

KW - 4th dose

KW - AZD1222

KW - BNT162b2

KW - booster

KW - COVID-19

KW - Southeast Asia

KW - Thailand

KW - vaccine effectiveness

UR - http://www.scopus.com/inward/record.url?scp=85136224339&partnerID=8YFLogxK

U2 - 10.1080/14760584.2022.2110073

DO - 10.1080/14760584.2022.2110073

M3 - Letter

C2 - 35968671

AN - SCOPUS:85136224339

SN - 1476-0584

VL - 21

SP - 1355

EP - 1357

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

IS - 9

ER -

Further implications on the global real-world vaccine effectiveness against SARS-CoV-2

Keywords

UN SDGs

Access to Document

Other files and links

Cite this